IS5304A - Inhaled pre-liposome powders stabilized with tocopherol - Google Patents
Inhaled pre-liposome powders stabilized with tocopherolInfo
- Publication number
- IS5304A IS5304A IS5304A IS5304A IS5304A IS 5304 A IS5304 A IS 5304A IS 5304 A IS5304 A IS 5304A IS 5304 A IS5304 A IS 5304A IS 5304 A IS5304 A IS 5304A
- Authority
- IS
- Iceland
- Prior art keywords
- tocopherol
- inhaled
- liposome
- powders stabilized
- stabilized
- Prior art date
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title 1
- 239000002502 liposome Substances 0.000 title 1
- 239000000843 powder Substances 0.000 title 1
- 229960001295 tocopherol Drugs 0.000 title 1
- 229930003799 tocopherol Natural products 0.000 title 1
- 235000010384 tocopherol Nutrition 0.000 title 1
- 239000011732 tocopherol Substances 0.000 title 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88441997A | 1997-06-27 | 1997-06-27 | |
| PCT/SE1998/001090 WO1999000111A1 (en) | 1997-06-27 | 1998-06-08 | Proliposome powders for inhalation stabilised by tocopherol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5304A true IS5304A (en) | 1999-12-15 |
Family
ID=25384589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5304A IS5304A (en) | 1997-06-27 | 1999-12-15 | Inhaled pre-liposome powders stabilized with tocopherol |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1001749A1 (en) |
| JP (1) | JP2002510311A (en) |
| KR (1) | KR20010014163A (en) |
| CN (1) | CN1260713A (en) |
| AU (1) | AU729100B2 (en) |
| BR (1) | BR9810280A (en) |
| CA (1) | CA2295028A1 (en) |
| EE (1) | EE9900601A (en) |
| HU (1) | HUP0003207A3 (en) |
| ID (1) | ID23192A (en) |
| IL (1) | IL133478A0 (en) |
| IS (1) | IS5304A (en) |
| NO (1) | NO996439L (en) |
| NZ (1) | NZ501672A (en) |
| PL (1) | PL337723A1 (en) |
| SK (1) | SK184899A3 (en) |
| TR (1) | TR199903271T2 (en) |
| WO (1) | WO1999000111A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| EP1138311A1 (en) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Proliposomes |
| EP1138310A1 (en) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Proliposomes |
| EP1138313A1 (en) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Proliposomes |
| PL1888033T3 (en) * | 2005-06-09 | 2014-09-30 | Meda Ab | Method and composition for treating inflammatory disorders |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| JP6458322B2 (en) * | 2013-05-06 | 2019-01-30 | ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． | Powdered vitamin E preparation |
| WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| CN105078963B (en) * | 2015-09-29 | 2018-06-22 | 中山大学 | Alpha-tocopherol is preparing the application in treating snail fever drug |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| WO2020018974A1 (en) | 2018-07-20 | 2020-01-23 | Lipocine Inc. | Liver disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2081474A1 (en) * | 1990-05-08 | 1991-11-09 | Manzer Durrani | Direct spray-dried drug/lipid powder composition |
| AR002009A1 (en) * | 1994-12-22 | 1998-01-07 | Astra Ab | PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE MANUFACTURE OF A PROLIPOSOMA POWDER AS USED IN SUCH COMPOSITION, PROCEDURE FOR LAMANUFACTURE OF SUCH COMPOSITION, USE OF SUCH PHARMACEUTICAL COMPOSITION IN THE MANUFACTURE OF A DISPOSAL MEDICINAL PRODUCT. |
-
1998
- 1998-06-08 AU AU79456/98A patent/AU729100B2/en not_active Ceased
- 1998-06-08 EE EEP199900601A patent/EE9900601A/en unknown
- 1998-06-08 BR BR9810280-0A patent/BR9810280A/en not_active IP Right Cessation
- 1998-06-08 EP EP98929963A patent/EP1001749A1/en not_active Withdrawn
- 1998-06-08 CA CA002295028A patent/CA2295028A1/en not_active Abandoned
- 1998-06-08 ID IDW991656A patent/ID23192A/en unknown
- 1998-06-08 CN CN98806377A patent/CN1260713A/en active Pending
- 1998-06-08 IL IL13347898A patent/IL133478A0/en unknown
- 1998-06-08 KR KR1019997012234A patent/KR20010014163A/en not_active Withdrawn
- 1998-06-08 HU HU0003207A patent/HUP0003207A3/en unknown
- 1998-06-08 NZ NZ501672A patent/NZ501672A/en unknown
- 1998-06-08 SK SK1848-99A patent/SK184899A3/en unknown
- 1998-06-08 TR TR1999/03271T patent/TR199903271T2/en unknown
- 1998-06-08 WO PCT/SE1998/001090 patent/WO1999000111A1/en not_active Ceased
- 1998-06-08 JP JP50548099A patent/JP2002510311A/en active Pending
- 1998-06-08 PL PL98337723A patent/PL337723A1/en unknown
-
1999
- 1999-12-15 IS IS5304A patent/IS5304A/en unknown
- 1999-12-23 NO NO996439A patent/NO996439L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK184899A3 (en) | 2000-05-16 |
| KR20010014163A (en) | 2001-02-26 |
| CN1260713A (en) | 2000-07-19 |
| CA2295028A1 (en) | 1999-01-07 |
| EP1001749A1 (en) | 2000-05-24 |
| NZ501672A (en) | 2001-06-29 |
| AU7945698A (en) | 1999-01-19 |
| TR199903271T2 (en) | 2000-08-21 |
| NO996439D0 (en) | 1999-12-23 |
| BR9810280A (en) | 2000-09-12 |
| PL337723A1 (en) | 2000-08-28 |
| IL133478A0 (en) | 2001-04-30 |
| JP2002510311A (en) | 2002-04-02 |
| AU729100B2 (en) | 2001-01-25 |
| HUP0003207A2 (en) | 2001-02-28 |
| NO996439L (en) | 2000-02-28 |
| EE9900601A (en) | 2000-08-15 |
| ID23192A (en) | 2000-03-23 |
| WO1999000111A1 (en) | 1999-01-07 |
| HUP0003207A3 (en) | 2001-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04420B1 (en) | Powder inhaler | |
| NO990272D0 (en) | Powder inhaler | |
| DE69708327D1 (en) | POWDER INHALATOR | |
| ID24472A (en) | MAKING POWDER AGLOMERATE | |
| IS5487A (en) | inhaler | |
| ID18427A (en) | POWDER POWDER | |
| DE69841276D1 (en) | Respirator | |
| FI942196A7 (en) | Powder inhaler | |
| NO2006014I1 (en) | Insulin glulisin | |
| DE69838271D1 (en) | Improved respirator | |
| IS5878A (en) | Powder for lungs | |
| IS5304A (en) | Inhaled pre-liposome powders stabilized with tocopherol | |
| FI964595L (en) | Powder inhaler | |
| ATE281836T1 (en) | STABILIZED TIBOLONE PREPARATIONS | |
| FR2763507B1 (en) | INHALER | |
| DE59909297D1 (en) | Carbonyleisensilizid powder | |
| DE69824327D1 (en) | inhaler | |
| FI955441L (en) | Powder inhaler | |
| DE69823490D1 (en) | antiperspirant PREPARATION | |
| NO20003182L (en) | Powder Inhalation Procedure | |
| DE69937138D1 (en) | COMPOSITE POWDER | |
| ID19844A (en) | POWDER COMPONENTS | |
| SE9703829D0 (en) | Powder inhalation | |
| DE59807895D1 (en) | POWDER KLARLACK | |
| IT243365Y1 (en) | IMPROVED INHALER |